American scientists are said to be working on a “space vaccine” that could also improve the lives of elderly residents.
Researchers at the University of Central Florida (UCF) will collaborate with biotechnology company Vaxxinity to develop a vaccine to prevent and alleviate musculoskeletal weakness. Miami Herald Saturday morning.
This collaboration, supported by government funding, aims to treat atrophy as well as bone and muscle loss, a common health problem among astronauts undertaking long-term weightless journeys, but also among the elderly.
The number of people ages 85 and older is expected to triple by 2060 in the United States. Research that could lead to longer, healthier lives has become increasingly important to American researchers in this context.
“We look forward to collaborating with Vaxxinity on this research and applying its unique technology to benefit our planet’s aging population and future space travelers,” Deborah, Vice President of Business Affairs at Vaxxinity, said in an announcement. German.
If all goes well, human clinical trials of vaccines could begin as early as 2025, said Lou Rees, co-founder and CEO of Vaxxinity. Miami Herald.
“Music guru. Incurable web practitioner. Thinker. Lifelong zombie junkie. Tv buff. Typical organizer. Evil beer scholar.”
More Stories
When even teachers buy peace with candy and screens!
Rimouski: Saint Laurent Distillery officially declares bankruptcy
TVA Group announces the end of its broadcast of local newscasts in Quebec City on weekends